<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37851044</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-6899</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Continuum (Minneapolis, Minn.)</Title><ISOAbbreviation>Continuum (Minneap Minn)</ISOAbbreviation></Journal><ArticleTitle>Multidisciplinary Clinics in Neuromuscular Medicine.</ArticleTitle><Pagination><StartPage>1585</StartPage><EndPage>1594</EndPage><MedlinePgn>1585-1594</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1212/CON.0000000000001340</ELocationID><Abstract><AbstractText>Multidisciplinary care is comprehensive, coordinated clinical care across medical disciplines and allied health professions. Neuromuscular disorders, such as amyotrophic lateral sclerosis and muscular dystrophies, are often associated with disabling weakness and extramuscular symptoms and may benefit from care in a model that consolidates numerous clinic visits into a single more efficient multidisciplinary clinic visit. The goal of the neuromuscular multidisciplinary care model is to improve patient outcomes, patient satisfaction, quality of life, access to medications and equipment, and survival. Although the costs of running a multidisciplinary clinic are high, they are likely associated with cost savings from the patient's perspective. Several barriers to acceptance of multidisciplinary clinics include the distance needed to travel to the clinic and the duration of the clinic visit. Telehealth multidisciplinary clinic visits may address some of these concerns. Further study is needed to understand the value of multidisciplinary clinics and is a necessary step toward creating a sustainable model.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 American Academy of Neurology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gwathmey</LastName><ForeName>Kelly</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Heiman-Patterson</LastName><ForeName>Terry D</ForeName><Initials>TD</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Continuum (Minneap Minn)</MedlineTA><NlmUniqueID>9509333</NlmUniqueID><ISSNLinking>1080-2371</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017216" MajorTopicYN="Y">Telemedicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000553" MajorTopicYN="N">Ambulatory Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009468" MajorTopicYN="Y">Neuromuscular Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>18</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>18</Day><Hour>11</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37851044</ArticleId><ArticleId IdType="doi">10.1212/CON.0000000000001340</ArticleId><ArticleId IdType="pii">00132979-202310000-00016</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Miller RG, Jackson CE, Kasarskis EJ, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American. Neurology 2009;73(15):1227&#x2013;1233. doi:10.1212/WNL.0b013e3181bc01a4</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181bc01a4</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayanaswami P, Carter G, David W, Weiss M, Amato AA. Evidence-based guideline summary: diagnosis and treatment of limb-girdle and distal dystrophies: report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neurology. Neurology 2015;83(16):1720&#x2013;1721. doi:10.1212/WNL.0000000000000892</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000892</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang CH, Finkel RS, Bertini ES, et al. Consensus statement for standard of care in spinal muscular atrophy. J Child Neurol 2007;22(8):1027&#x2013;1049. doi:10.1177/0883073807305788</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0883073807305788</ArticleId></ArticleIdList></Reference><Reference><Citation>Birnkrant DJ, Bushby K, Bann CM, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol 2018;17(3):251&#x2013;267. doi:10.1016/S1474-4422(18)30024-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30024-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard I, Potts A. Interprofessional care for neuromuscular disease. Curr Treat Options Neurol 2019;21(8):35.doi:10.1007/s11940-019-0576-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11940-019-0576-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith TM. What is value-based care? These are the key elements. Accessed July 25, 2023. ama-assn.org/practice-management/payment-delivery-models/what-value-based-care-these-are-key-elements</Citation></Reference><Reference><Citation>Berwick DM, Nolan TW, Whittington J. The triple aim: care, health, and cost. Health Aff (Millwood) 2008;27(3):759&#x2013;769. doi:10.1377/hlthaff.27.3.759</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.27.3.759</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooney J, Byrne S, Heverin M, et al. A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland. J Neurol Neurosurg Psychiatry 2015;86(5):496&#x2013;501. doi:10.1136/jnnp-2014-309601</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2014-309601</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Bottacchi E, Buffa C, Mutani R, Mora G; PARALS. Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities. J Neurol Neurosurg Psychiatry 2006;77(8):948&#x2013;950. doi:10.1136/jnnp.2005.083402</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2005.083402</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Berg JP, Kalmijn S, Lindeman E, et al. Multidisciplinary ALS care improves quality of life in patients with ALS. Neurology 2005;65(8):1264&#x2013;1267. doi:10.1212/01.wnl.0000180717.29273.12</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000180717.29273.12</ArticleId></ArticleIdList></Reference><Reference><Citation>Vry J, Gramsch K, Rodger S, et al. European cross-sectional survey of current care practices for Duchenne muscular dystrophy reveals regional and age-dependent differences. J Neuromuscul Dis 2016;3(4):517&#x2013;527. doi:10.3233/JND-160185</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JND-160185</ArticleId></ArticleIdList></Reference><Reference><Citation>Otto C, Steffensen BF, H&#xf8;jberg A-L, et al. Predictors of Health-Related Quality of Life in boys with Duchenne muscular dystrophy from six European countries. J Neurol 2017;264(4):709&#x2013;723. doi:10.1007/s00415-017-8406-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-017-8406-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Boylan K, Levine T, Lomen-Hoerth C, et al. Prospective study of cost of care at multidisciplinary ALS centers adhering to American Academy of Neurology (AAN) ALS practice parameters. Amyotroph Lateral Scler Frontotemporal Degener 2015;17(1-2):119&#x2013;127. doi:10.3109/21678421.2015.1091478</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1091478</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S, Nicholson K, Leigh F, et al. Developing multidisciplinary clinics for neuromuscular care and research. Muscle Nerve 2017;56(5):848&#x2013;858. doi:10.1002/mus.25725</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.25725</ArticleId></ArticleIdList></Reference><Reference><Citation>Galvin M, Ryan P, Maguire S, et al. The path to specialist multidisciplinary care in amyotrophic lateral sclerosis: a population- based study of consultations, interventions and costs. PLoS One 2017;12(6):e0179796. doi:10.1371/journal.pone.0179796</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0179796</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladman M, Zinman L. The economic impact of amyotrophic lateral sclerosis: a systematic review. Expert Rev Pharmacoecon Outcomes Res 2015;15(3):439&#x2013;450. doi:0.1586/14737167.2015.1039941</Citation><ArticleIdList><ArticleId IdType="doi">doi:0.1586/14737167.2015.1039941</ArticleId></ArticleIdList></Reference><Reference><Citation>Horton DK, Graham S, Punjani R, et al. A spatial analysis of amyotrophic lateral sclerosis (ALS) cases in the United States and their proximity to multidisciplinary ALS clinics, 2013. Amyotroph Lateral Scler Frontotemporal Degener 2018;19(1-2):126&#x2013;133. doi:10.1080/21678421.2017.1406953</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1406953</ArticleId></ArticleIdList></Reference><Reference><Citation>Schellenberg KL, Hansen G. Patient perspectives on transitioning to amyotrophic lateral sclerosis multidisciplinary clinics. J Multidiscip Healthc 2018;11:519&#x2013;524. doi:10.2147/JMDH.S177563</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JMDH.S177563</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P, Raymond J, Punjani R, et al. Prevalence of amyotrophic lateral sclerosis (ALS), United States, 2016. Amyotroph Lateral Scler Frontotemporal Degener 2022;23(3-4):220&#x2013;225. doi:10.1080/21678421.2021.1949021</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2021.1949021</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute of Neurological Disorders and Stroke. Amyotrophic lateral sclerosis. Accessed July 25, 2023. ninds.nih.gov/sites/default/files/migrate-documents/ALS_FactSheet-E_508C.pdf</Citation></Reference><Reference><Citation>Hogden A, Foley G, Henderson RD, James N, Aoun SM. Amyotrophic lateral sclerosis: improving care with a multidisciplinary approach. J Multidiscip Healthc 2017;10:205&#x2013;215. doi:10.2147/JMDH.S134992</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JMDH.S134992</ArticleId></ArticleIdList></Reference><Reference><Citation>Kvam KA, Benatar M, Brownlee A, et al. Amyotrophic lateral sclerosis quality measurement set 2022 update: quality improvement in neurology. Neurology 2023;101(5):223&#x2013;232. doi:10.1212/WNL.0000000000207166</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000207166</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Abrahams S, Borasio GD, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)&#x2013;revised report of an EFNS task force. Eur J Neurol 2012;19(3):360&#x2013;375. doi:10.1111/j.1468-1331.2011.03501.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2011.03501.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000. J Neurol Neurosurg Psychiatry 2003;74(9):1258&#x2013;1261. doi:1136/jnnp.74.9.1258</Citation><ArticleIdList><ArticleId IdType="doi">doi:1136/jnnp.74.9.1258</ArticleId></ArticleIdList></Reference><Reference><Citation>Klav&#x17e;ar P, Koritnik B, Leonardis L, et al. Improvements in the multidisciplinary care are beneficial for survival in amyotrophic lateral sclerosis (ALS): experience from a tertiary ALS center. Amyotroph Lateral Scler Frontotemporal Degener 2020;21(3-4):203&#x2013;208. doi:10.1080/21678421.2020.1746809</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1746809</ArticleId></ArticleIdList></Reference><Reference><Citation>de Almeida FEO, do Carmo Santana AK, de Carvalho FO. Multidisciplinary care in amyotrophic lateral sclerosis: a systematic review and meta-analysis. Neurol Sci 2021;42(3):911&#x2013;923. doi:10.1007/s10072-020-05011-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-05011-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin S, Trevor-Jones E, Khan S, et al. The benefit of evolving multidisciplinary care in ALS: a diagnostic cohort survival comparison. Amyotroph Lateral Scler Frontotemporal Degener 2017;18(7-8):569&#x2013;575. doi:10.1080/21678421.2017.1349151</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1349151</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugisawa T, Morioka H, Hirayama T, Kano O, Ebihara S. Multidisciplinary clinic contributes to the decreasing trend in the number of emergency hospitalizations for amyotrophic lateral sclerosis in Japan. J Clin Neurosci 2023;107:133&#x2013;137. 1doi:0.1016/j.jocn.2022.10.011</Citation><ArticleIdList><ArticleId IdType="doi">doi:0.1016/j.jocn.2022.10.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Riemenschneider K, Forshew D, Miller R. Multidisciplinary clinics: optimizing treatment for patients with amyotrophic lateral sclerosis. Neurodegener Dis Manag 2013;3(2):157&#x2013;167. doi:10.2217/nmt.13.7</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/nmt.13.7</ArticleId></ArticleIdList></Reference><Reference><Citation>Aridegbe T, Kandler R, Walters SJ, et al. The natural history of motor neuron disease: assessing the impact of specialist care. Amyotroph Lateral Scler Frontotemporal Degener 2013;14(1):13&#x2013;19. doi:10.3109/17482968.2012.690419</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.690419</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien MR, Whitehead B, Jack BA, Mitchell JD. From symptom onset to a diagnosis of amyotrophic lateral sclerosis/motor neuron disease (ALS/MND): experiences of people with ALS/MND and family carers - a qualitative study. Amyotroph Lateral Scler 2011;12(2):97&#x2013;104. doi:10.3109/17482968.2010.546414</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.546414</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephens HE, Young J, Felgoise SH, Simmons Z. A qualitative study of multidisciplinary ALS clinic use in the United States. Amyotroph Lateral Scler Frontotemporal Degener 2015;17(1-2):55&#x2013;61. doi:10.3109/21678421.2015.1069851</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1069851</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryder S, Leadley RM, Armstrong N, et al. The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review. Orphanet J Rare Dis 2017;12(1):79. doi:10.1186/s13023-017-0631-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-017-0631-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Guiraud S, Chen H, Burns DT, Davies KE. Advances in genetic therapeutic strategies for Duchenne muscular dystrophy. Exp Physiol 2015;100(12):1458&#x2013;1467. doi:10.1113/EP085308</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP085308</ArticleId></ArticleIdList></Reference><Reference><Citation>Bushby K, Finkel R, Birnkrant DJ, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol 2010;9(2):177&#x2013;189. doi:10.1016/S1474-4422(09)70272-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(09)70272-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Bushby K, Finkel R, Birnkrant DJ, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 2010;9(1):77&#x2013;93. doi:10.1016/S1474-4422(09)70271-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(09)70271-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Birnkrant DJ, Bushby K, Bann CM, et al. Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan. Lancet Neurol 2018;17(5):445&#x2013;455. doi:10.1016/S1474-4422(18)30026-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30026-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Birnkrant DJ, Bushby K, Bann CM, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol 2018;17(3):251&#x2013;267. doi:10.1016/S1474-4422(18)30024-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30024-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinnett K, Dowling JJ, Mendell JR. The certified Duchenne care center program. Neuromuscul Disord 2016;26(12):853&#x2013;859. doi:10.1016/j.nmd.2016.09.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2016.09.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Passamano L, Taglia A, Palladino A, et al. Improvement of survival in Duchenne muscular dystrophy: retrospective analysis of 835 patients. Acta Myol 2012;31(2):121&#x2013;125.</Citation></Reference><Reference><Citation>Leigh F, Ferlini A, Biggar D, et al. Neurology care, diagnostics, and emerging therapies of the patient with Duchenne muscular dystrophy. Pediatrics 2018;142(suppl 2):S5&#x2013;S16. doi:10.1542/peds.2018-0333C</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2018-0333C</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway KM, Grosse SD, Ouyang L, Street N, Romitti PA. Direct costs of adhering to selected Duchenne muscular dystrophy care considerations: estimates from a midwestern state. Muscle Nerve 2022;65(5):574&#x2013;580. doi:10.1002/mus.27505</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27505</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrans DGM, Abbott D, Peay HL, et al. Transition in Duchenne muscular dystrophy: an expert meeting report and description of transition needs in an emergent patient population: (Parent Project Muscular Dystrophy Transition Expert Meeting 17-18 June 2011, Amsterdam, The Netherlands). Neuromuscul Disord 2013;23(3):283&#x2013;286. doi:0.1016/j.nmd.2012.08.009</Citation><ArticleIdList><ArticleId IdType="doi">doi:0.1016/j.nmd.2012.08.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitacca M, Comini L, Tentorio M, et al. A pilot trial of telemedicine-assisted, integrated care for patients with advanced amyotrophic lateral sclerosis and their caregivers. J Telemed Telecare 2010;16(2):83&#x2013;88. doi:10.1258/jtt.2009.090604</Citation><ArticleIdList><ArticleId IdType="doi">10.1258/jtt.2009.090604</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitacca M, Comini L, Assoni G, et al. Tele-assistance in patients with amyotrophic lateral sclerosis: long term activity and costs. Disabil Rehabil Assist Technol 2012;7(6):494&#x2013;500. doi:10.3109/17483107.2011.652999</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17483107.2011.652999</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto A, Almeida JP, Pinto S, et al. Home telemonitoring of non-invasive ventilation decreases healthcare utilisation in a prospective controlled trial of patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2010;81(11):1238&#x2013;1242. doi:10.1136/jnnp.2010.206680</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.206680</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijeweme-d&#x2019;Hollosy WO, Janssen EPF, Huis in &#x2019;t Veld RMHA, et al. Tele-treatment of patients with amyotrophic lateral sclerosis (ALS). J Telemed Telecare 2006;12(suppl 1):31&#x2013;34. doi:10.1258/135763306777978434</Citation><ArticleIdList><ArticleId IdType="doi">10.1258/135763306777978434</ArticleId></ArticleIdList></Reference><Reference><Citation>McClellan F, Washington M, Ruff R, Selkirk SM. Early and innovative symptomatic care to improve quality of life of ALS patients at Cleveland VA ALS Center. J Rehabil Res Dev 2013;50(4):7&#x2013;16. doi:10.1682/jrrd.2013.05.0107</Citation><ArticleIdList><ArticleId IdType="doi">10.1682/jrrd.2013.05.0107</ArticleId></ArticleIdList></Reference><Reference><Citation>Selkirk SM, Washington MO, McClellan F, et al. Delivering tertiary centre specialty care to ALS patients via telemedicine: a retrospective cohort analysis. Amyotroph Lateral Scler Frontotemporal Degener 2017;18(5-6):324&#x2013;332. doi:10.1080/21678421.2017.1313867</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1313867</ArticleId></ArticleIdList></Reference><Reference><Citation>Geronimo A, Wright C, Morris A, et al. Incorporation of telehealth into a multidisciplinary ALS clinic: feasibility and acceptability. Amyotroph Lateral Scler Frontotemporal Degener 2017;18(7-8):555&#x2013;561. doi:10.1080/21678421.2017</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson EV, Baird WO, Cooper CL, et al. Using technology to improve access to specialist care in amyotrophic lateral sclerosis: a systematic review. Amyotroph Lateral Scler Frontotemporal Degener 2016;17(5-6):313&#x2013;324. doi:0.3109/21678421.2016.1165255</Citation><ArticleIdList><ArticleId IdType="doi">doi:0.3109/21678421.2016.1165255</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulley MT, Brittain R, Hodges W, et al. Multidisciplinary amyotrophic lateral sclerosis telemedicine care: the store and forward method. Muscle and Nerve 2019;59(1):34&#x2013;39. doi:10.1002/mus.26170</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26170</ArticleId></ArticleIdList></Reference><Reference><Citation>Giler G, Hollin I, Heiman-Patterson TD; the NEALs Clinical Research Group. Care and financial considerations at the multidisciplinary ALS clinics. Poster presented at: 21st Annual Northeast ALS Consortium Meeting, October 6-7, 2021; Chicago, IL.</Citation></Reference><Reference><Citation>Bromberg MB, Schenkenberg T, Brownell AA. A survey of stress among amyotrophic lateral sclerosis care providers. Amyotroph Lateral Scler 2011;12(3):162&#x2013;167. doi:10.3109/17482968.2011.562512</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.562512</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogden AV, Greenfield D, Nugus P, Kiernan MC. Engaging in patient decision-making in multidisciplinary care for amyotrophic lateral sclerosis: the views of health professionals. Patient Prefer Adherence 2012;6:691&#x2013;701. doi:10.2147/PPA.S36759</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/PPA.S36759</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>